Please login to the form below

Not currently logged in
Email:
Password:

Elizabeth Egan joins Havas Lynx

She joins as the agency’s new managing director

Elizabeth EganGlobal healthcare communications agency Havas Lynx has appointed Elizabeth Egan as its new managing director, a role that will see her lead the agency’s expansion of its London office.

Egan, who has nearly 30 years’ experience working with AstraZeneca, Weight Watchers and Electronic Arts, will lead the London-based team to deliver ‘innovative’ communications that equip patients and healthcare professionals with the tools they need to improve healthcare systems.

She said: “This is an opportunity that really excites me and gives me the chance to connect patients, professionals and brands with information, services and tools that drive new relationships and better outcomes.

Havas is all about bringing ‘change’ in healthcare and the London office has a major role to play in delivering campaigns to our worldwide client base that reiterative this message.”

Egan succeeds Tim Woodcock, who launched the London office in 2012 and is now working with the senior leadership team to execute plans for further international growth.

David Hunt, chief executive officer of Havas Lynx, said: “[Egan] is extremely passionate about people and leveraging their skills and creative thinking to deliver solutions.

“Her experience of the consumer sphere and the retention of consumers on regime plans will also be very valuable to a number of our future campaigns.”

1st May 2018

From: PME

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....